NEW YORK, Sept. 26, 2016 /PRNewswire/ -- The following
statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Tobira
Therapeutics, Inc. ("Tobira") (NASDAQ: TBRA) stock prior to
September 20, 2016.
You are hereby notified that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of
the sale of Tobira to Allergan plc for $28.35 per share. The deal also includes up to
$49.84 per share in Contingent Value
Rights, payable upon the successful completion of certain
milestones. The deal has a potential approximate value of
$1.695 billion. To learn more about
the action and your rights, go to:
http://zlk.9nl.com/tobira or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut, California, and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities lawsuits and have recovered hundreds of millions of
dollars for aggrieved shareholders. For more information,
please feel free to contact any of the attorneys listed below.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-announces-an-investigation-concerning-whether-the-sale-of-tobira-therapeutics-inc-to-allergan-plc-for-2835-per-share-is-fair-to-shareholders----tbra-300334055.html
SOURCE Levi & Korsinsky, LLP